Skip to main navigation Skip to search Skip to main content

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis

  • Sheba Medical Center at Tel Hashomer
  • Shaare Zedek Medical Center
  • Hebrew University of Jerusalem
  • Oncology
  • Western Galilee Medical Center of Nahariya
  • Assuta Medical Center
  • Technion-Israel Institute of Technology
  • Tel Aviv Sourasky Medical Center

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Purpose: We recently showed that prophylactic breast irradiation (PBI) reduces the risk of contralateral breast cancer in BRCA mutation carriers undergoing treatment for early breast cancer. It has been suggested that Background Parenchymal Enhancement (BPE) may be a biomarker for increased risk of breast cancer. Methods: For participants in the trial we reviewed the MRI prior to enrollment and following radiation treatment and scored the contralateral breast for BPE and density. Results: Significant reduction of BPE was more commonly noted following PBI (p = 0.011) compared to the control group. Conclusion: Reduction of BPE by PBI may contribute to its prophylactic effect.

Original languageEnglish
Pages (from-to)70-73
Number of pages4
JournalBreast
Volume49
DOIs
StatePublished - Feb 2020

Funding

FundersFunder number
Israel Cancer AssociationC-20190082

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • BPE
    • BRCA
    • Breast cancer
    • Prophylactic breast irradiation

    Fingerprint

    Dive into the research topics of 'Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis'. Together they form a unique fingerprint.

    Cite this